ClinicalTrials.Veeva
Menu

Find clinical trials for Non-Small-Cell Lung Cancer in San Antonio, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Non-Small-Cell Lung Carcinoma
Lung Cancer
Cancer
Carcinoma
Squamous Cell Carcinoma of Head and Neck
Colorectal Cancer
Triple Negative Breast Cancer

Non-Small-Cell Lung Cancer trials near San Antonio, TX, USA:

Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07)

in participants with no prior therapy for advanced or metastatic non-squamous non-small cell lung cancer...

Enrolling
Metastatic Non Small Cell Lung Cancer
Drug: Carboplatin
Drug: Datopotamab Deruxtecan

Phase 3

Daiichi Sankyo
Daiichi Sankyo

San Antonio, Texas, United States and 191 other locations

alone for the treatment of locally advanced or metastatic non-small cell lung cancer. Some lung ...

Active, not recruiting
Non-Small Cell Lung Cancer
Drug: Pemetrexed/Carboplatin
Drug: Pemetrexed/Cisplatin

Phase 3

AstraZeneca
AstraZeneca

San Antonio, Texas, United States and 152 other locations

This is an open-label, non-controlled study conducted in two parts - Part A (dose escalation) followed by Part B (dose expansion)....

Active, not recruiting
Colorectal Cancer
Pancreatic Cancer
Drug: NBF-006

Phase 1

Nitto BioPharma

San Antonio, Texas, United States and 8 other locations

with osimertinib in subjects with locally advanced or metastatic non-small cell lung cancer (NSCLC)....

Active, not recruiting
Lung Cancer
Drug: Itacitinib
Drug: Osimertinib

Phase 1, Phase 2

Incyte
Incyte

San Antonio, Texas, United States and 30 other locations

A Phase 1/1b dose finding study to determine the OBD(s) and RP2D(s) of BMF-219, a covalent menin inhibitor small molecule, in subjects with ...

Enrolling
Stage III Non-small Cell Lung Cancer
Stage III Pancreatic Cancer
Drug: BMF-219

Phase 1

Biomea Fusion

San Antonio, Texas, United States and 22 other locations

The main purpose of the study is to evaluate the safety of GDC-1971 in combination with either osimertinib or cetuximab. The study consists of a dose...

Enrolling
Non-Small Cell Lung Cancer
Colorectal Cancer
Drug: GDC-1971
Drug: Osimertinib

Phase 1

Genentech
Genentech

San Antonio, Texas, United States and 9 other locations

pembrolizumab alone in participants with advanced or metastatic non-small cell lung cancer (NSCLC)....

Enrolling
Metastatic Non Small Cell Lung Cancer
Drug: Datopotamab Deruxtecan
Drug: Pembrolizumab

Phase 3

Daiichi Sankyo
Daiichi Sankyo

San Antonio, Texas, United States and 230 other locations

status as determined by Version 8 of the American Joint Committee on Cancer/Union for International Cancer Control NSCLC staging sy...

Enrolling
Non-Small Cell Lung Cancer
Drug: Durvalumab
Drug: Entrectinib

Phase 3

Roche
Roche

San Antonio, Texas, United States and 162 other locations

Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. Non-Small Cell...

Enrolling
Head and Neck Squamous Cell Carcinoma
Non-Small Cell Lung Cancer
Drug: Budigalimab
Drug: ABBV-514

Phase 1

AbbVie
AbbVie

San Antonio, Texas, United States and 22 other locations

as monotherapy or in combination with chemotherapy, versus SoC chemotherapy alone, for the treatment of patients with resectable EGFRm Non-S ...

Enrolling
Non-Small Cell Lung Cancer
Drug: Carboplatin
Drug: Cisplatin

Phase 3

AstraZeneca
AstraZeneca

San Antonio, Texas, United States and 223 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems